DEXCOM INC — Director's Dealing 2015

Nov 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-11-10

Reporting Person: Pacelli Steven Robert (EVP, Strategy & Corp. Dev.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-10	Common Stock	M	14000.0	$20.65	Acquired	230214	Direct
2015-11-10	Common Stock	S	14000.0	$84.7291	Disposed	216214	Direct
2015-11-10	Common Stock	M	7562.0	$7.63	Acquired	223776	Direct
2015-11-10	Common Stock	S	7562.0	$84.6965	Disposed	216214	Direct
2015-11-10	Common Stock	M	3438.0	$7.25	Acquired	219652	Direct
2015-11-10	Common Stock	S	3438.0	$84.6965	Disposed	216214	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-10	Incentive Stock Option (right to buy)	$7.25	M	3438.0	Disposed	2017-03-09	Common Stock (3438)	Direct
2015-11-10	Incentive Stock Option (right to buy)	$7.63	M	7562.0	Disposed	2018-05-19	Common Stock (7562)	Direct
2015-11-10	Non-Qualified Stock Option (right to buy)	$20.65	M	14000.0	Disposed	2016-04-17	Common Stock (14000)	Direct

Footnotes

F1: Included in this number are 92,437 unvested restricted stock units, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 35,500 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 11,937 of which were granted on March 11, 2013 and shall vest through March 11, 2016.